Biotech Acquisition Company Cl A (BIOT)
Biotech Acquisition Company Cl A (BIOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,323 | 14,061 | 4,677 | -6,865 | 421 |
| Other Working Capital | 3,022 | 2,920 | 1,795 | 105 | 86 |
| Other Operating Activity | -18,731 | -17,223 | -6,574 | 5,295 | -1,661 |
| Operating Cash Flow | $-386 | $-242 | $-102 | $-1,465 | $-1,154 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | N/A | N/A | -230,000 | -230,000 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-230,000 | $-230,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 305 | 150 | N/A | 61 | 61 |
| Debt Repayment | 3 | 3 | N/A | 1 | 1 |
| Common Stock Issued | N/A | N/A | N/A | 232,000 | 232,000 |
| Other Financing Activity | 0 | 0 | 115 | -505 | -505 |
| Financing Cash Flow | $308 | $153 | $115 | $231,557 | $231,557 |
| Beginning Cash Position | 91 | 91 | 91 | N/A | N/A |
| End Cash Position | 13 | 2 | 104 | 91 | 402 |
| Net Cash Flow | $-78 | $-90 | $13 | $91 | $402 |
| Free Cash Flow | |||||
| Operating Cash Flow | -386 | -242 | -102 | -1,465 | -1,154 |
| Free Cash Flow | -386 | -242 | -102 | -1,465 | -1,154 |